Defective regulatory B-cell compartment in patients with immune thrombocytopenia
- 18 October 2012
- journal article
- research article
- Published by American Society of Hematology in Blood
- Vol. 120 (16), 3318-3325
- https://doi.org/10.1182/blood-2012-05-432575
Abstract
B lymphocytes producing antiplatelet autoantibodies play a major role in autoimmune thrombocytopenia (ITP). However, certain B cells, including the human CD19+CD24hiCD38hi subpopulation, possess regulatory functions mediated partly by IL-10. In a cohort of chronic ITP patients with low platelet counts who consisted of patients off treatment, we found a lower frequency of CD19+CD24hiCD38hi in the peripheral compartment of nonsplenectomized patients (P = .03). IL-10 expression after activation was decreased in all ITP circulating CD19+ subpopulations (P < .03), and inhibition of monocyte TNF-α expression by activated B cells was reduced in patients with platelet numbers of < 50 × 109 cells/L (P = .001), indicating that regulatory B cells of patients with ITP are functionally impaired in their ability to dampen monocyte activation. Interestingly, in nonsplenectomized patients whose platelet counts were elevated after treatment with thrombopoietic agents, the frequency of CD19+CD24hiCD38hi B cells was increased compared with those before treatment (P = .02). Altogether, these data indicate a compromised regulatory B-cell com-partment as an additional defect in immune regulation in patients with chronic ITP that may be restored in responders to thrombopoietic treatment.This publication has 44 references indexed in Scilit:
- Immunologic effects of rituximab on the human spleen in immune thrombocytopeniaBlood, 2011
- Characterization of a rare IL-10–competent B-cell subset in humans that parallels mouse regulatory B10 cellsBlood, 2011
- Improved regulatory T-cell activity in patients with chronic immune thrombocytopenia treated with thrombopoietic agentsBlood, 2010
- Romiplostim or Standard of Care in Patients with Immune ThrombocytopeniaThe New England Journal of Medicine, 2010
- B cells as therapeutic targets in SLENature Reviews Rheumatology, 2010
- Identification of a B cell signature associated with renal transplant tolerance in humansJCI Insight, 2010
- Regulatory B cells prevent and reverse allergic airway inflammation via FoxP3-positive T regulatory cells in a murine modelJournal of Allergy and Clinical Immunology, 2010
- CD19+CD24hiCD38hi B Cells Exhibit Regulatory Capacity in Healthy Individuals but Are Functionally Impaired in Systemic Lupus Erythematosus PatientsImmunity, 2010
- Defective circulating CD25 regulatory T cells in patients with chronic immune thrombocytopenic purpuraBlood, 2008
- Reduced Cd4+Cd25+ T cells in patients with idiopathic thrombocytopenic purpuraThrombosis Research, 2007